医疗警示配件在CKD中的试点研究
该试点研究纳入350例2-5期未透析CKD患者,前108例佩戴医疗警示配件(手镯或项链),后242例接受常规护理,中位随访分别为52和37个月。配件组与观察组的安全事件频率无差异,但配件组ESKD发生率显著较低(调整后HR 0.38,95%CI 0.16-0.94)。
要点
- 医疗警示配件未减少患者报告的安全事件。
- 配件使用与较低的ESKD风险相关(调整HR 0.38)。
- 配件对复合终点(ESKD或GFR下降50%)的早期获益限于23个月内。
核心结论
- 医疗警示配件未改变安全事件发生率,但与较低的ESKD发生率相关。
研究设计与样本
- 试点研究纳入350例2-5期未透析CKD患者,前108例佩戴医疗警示配件,后242例接受常规护理。
主要发现
- 配件组与观察组1类安全事件率分别为108.7和100.6次/100患者访视(P=0.13)。
- 配件组与观察组2类安全事件率分别为38.3和41.2次/100患者访视(P=0.23)。
- 配件组ESKD粗率HR为0.42(95%CI 0.20-0.89),调整后HR为0.38(95%CI 0.16-0.94)。
- 配件对ESKD或GFR下降50%复合终点的关联随时间变化,早期(至23个月)似有获益。
- 配件组与观察组在住院、死亡或所有结局复合终点发生率上无显著差异。
临床怎么用
- 医疗警示配件可能有助于改善CKD患者ESKD相关结局,但需进一步验证。
局限性
- 本研究为试点研究,样本量有限,非随机设计。
- 配件组与观察组随访时间不一致(中位52 vs 37个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Poor disease recognition may jeopardize the safety of CKD care. We examined safety events and outcomes in patients with CKD piloting a medical-alert accessory intended to improve disease recognition and an observational subcohort from the same population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We recruited 350 patients with stage 2-5 predialysis CKD. The first (pilot) 108 participants were given a medical-alert accessory (bracelet or necklace) indicating the diagnosis of CKD and displaying a website with safe CKD practices. The subsequent (observation) subcohort (n=242) received usual care. All participants underwent annual visits with ascertainment of patient-reported events (class 1) and actionable safety findings (class 2). Secondary outcomes included 50% GFR reduction, ESKD, and death. Cox proportional hazards assessed the association of the medical-alert accessory with outcomes. RESULTS: Median follow-up of pilot and observation subcohorts were 52 (interquartile range, 44-63) and 37 (interquartile range, 27-47) months, respectively. The frequency of class 1 and class 2 safety events reported at annual visits was not different in the pilot versus observation group, with 108.7 and 100.6 events per 100 patient-visits (P=0.13), and 38.3 events and 41.2 events per 100 patient visits (P=0.23), respectively. The medical-alert accessory was associated with lower crude and adjusted rate of ESKD versus the observation group (hazard ratio, 0.42; 95% confidence interval, 0.20 to 0.89; and hazard ratio, 0.38; 95% confidence interval, 0.16 to 0.94, respectively). The association of the medical-alert accessory with the composite endpoint of ESKD or 50% reduction GFR was variable over time but appeared to have an early benefit (up to 23 months) with its use. There was no significant difference in incidence of hospitalization, death, or a composite of all outcomes between medical-alert accessory users and the observational group. CONCLUSIONS: The medical-alert accessory was not associated with incidence of safety events but was associated with a lower rate of ESKD relative to usual care.
引用
- Farhy E, Diamantidis CJ, Doerfler RM, et al. Use of a Medical-Alert Accessory in CKD: A Pilot Study. Clin J Am Soc Nephrol. 2019. PMID: 31171589. doi:10.2215/CJN.13531118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。